Ovarian Cancer Stages

Ovarian cancer often develops with subtle warning signs, such as persistent abdominal bloating, pelvic discomfort, or changes in bowel habits, that are easily overlooked in its early stages. While risk factors include older age, family history, and inherited genetic mutations like BRCA1 or BRCA2, determining the exact stage of the disease is one of the most important steps in mapping out an effective, targeted treatment strategy.

How Ovarian Cancer Is Staged

To evaluate how far the cancer has progressed, gynecologic oncologists rely on standard staging frameworks established by the International Federation of Gynecology and Obstetrics (FIGO) and the American Joint Committee on Cancer (AJCC) TNM system. This approach evaluates the extent of the primary cancer (T), including whether it is confined to the ovaries or fallopian tubes or has spread within the pelvis or abdomen, whether regional retroperitoneal lymph nodes are involved (N), and whether the cancer has metastasized to distant sites (M).

Ovarian cancer is primarily staged surgically and pathologically through careful tissue and fluid evaluation during an initial staging or debulking procedure. However, when surgery cannot be performed immediately, a clinical stage may be assigned based on physical examination, tissue biopsy, and diagnostic imaging.

This staging framework primarily applies to epithelial ovarian, fallopian tube, and primary peritoneal cancers, which represent the vast majority of cases. Less common non-epithelial malignancies, such as germ cell and sex cord-stromal tumors, follow distinct clinical management pathways.

Stage 1 Ovarian Cancer

In Stage 1, the tumor is strictly confined to the ovaries or fallopian tubes and has not spread to nearby lymph nodes or distant organs. Stage 1 is subdivided based on whether one or both ovaries or fallopian tubes are involved and whether additional findings affect the substage:

• Stage 1A: The tumor is limited to a single ovary or fallopian tube. For ovarian tumors, the capsule remains completely intact; there is no tumor on the outer surface and no malignant cells are found in ascites or peritoneal washings.
• Stage 1B: The tumor involves both ovaries or fallopian tubes. For ovarian tumors, the outer capsules remain intact, there is no surface tumor, and no malignant cells are found in ascites or peritoneal washings.
• Stage 1C: The cancer is limited to one or both ovaries or fallopian tubes, but exhibits one of three specific findings:
  • Stage 1C1: Intraoperative surgical spill occurred during tumor removal.
  • Stage 1C2: The capsule ruptured prior to surgery, or tumor tissue is growing on the outer surface of an ovary or fallopian tube.
  • Stage 1C3: Malignant cells are detected in ascitic fluid or peritoneal washings.

“Once you were part of the Moffitt family, you never felt alone.”

-Donna, Ovarian Cancer Survivor

Request an Appointment

Stage 2 Ovarian Cancer

Stage 2 indicates that cancer has spread from one or both ovaries or fallopian tubes to other structures within the pelvis below the pelvic brim. It can also include primary peritoneal cancer confined to the pelvis. Stage 2 is divided into two substages:

• Stage 2A: The cancer has extended to or grown implants directly onto the uterus, ovaries, or fallopian tubes.
• Stage 2B: The cancer has spread to or invaded other intraperitoneal pelvic tissues, such as the bladder, sigmoid colon, or rectum.

Stage 3 Ovarian Cancer

In Stage 3, the cancer involves one or both ovaries or fallopian tubes, or originates in the primary peritoneum, with cytologically or histologically confirmed spread to the abdominal lining (peritoneum) outside the pelvis or to retroperitoneal lymph nodes:

• Stage 3A: Spread to retroperitoneal lymph nodes or microscopic peritoneal spread:
  • Stage 3A1: Cancer has spread to retroperitoneal (pelvic or para-aortic) lymph nodes only, with no peritoneal disease outside the pelvis.
  • Stage 3A2: Microscopic tumor deposits are identified on the abdominal lining (peritoneum) outside the pelvis, with or without retroperitoneal lymph node involvement.
• Stage 3B: Macroscopic (visible) tumor deposits on the abdominal lining outside the pelvis measuring 2 cm or smaller in greatest dimension, with or without retroperitoneal lymph node involvement.
• Stage 3C: Visible tumor deposits larger than 2 cm are present on the abdominal lining outside the pelvis, with or without retroperitoneal lymph node involvement. This stage also includes cancer that has extended to the capsule or outer surface of the liver or spleen without invading the internal tissue of either organ.

Stage 4 Ovarian Cancer

Stage 4 represents advanced, metastatic ovarian cancer where tumor cells have spread beyond the peritoneal cavity to distant organs or tissues. Peritoneal spread alone, even extensive tumor involvement throughout the abdominal cavity, does not qualify as Stage IV. For example, tumor implants restricted to the surface of the liver or spleen remain Stage 3C; Stage 4 requires distant spread, such as malignant pleural fluid, extra-abdominal metastasis, distant lymph-node involvement, or invasion into the internal tissue of the liver or spleen.

• Stage 4A: Fluid accumulation around the lungs (pleural effusion) contains confirmed malignant cells on pleural cytology.
• Stage 4B: Cancer has spread to the parenchymal (internal) tissue of the liver or spleen, or to extra-abdominal organs and distant lymph nodes (such as inguinal lymph nodes).

What Is the Prognosis for Stage 4 Metastatic Ovarian Cancer?

The prognosis for metastatic ovarian cancer can vary based on several factors, including the extent of the tumor and the patient’s age, overall health and response to therapy. While a diagnosis of advanced-stage ovarian cancer can seem overwhelming, many patients respond well to treatment and can manage the condition effectively.

Advances in surgery, chemotherapy, targeted therapies and maintenance treatments are continually improving outcomes and providing new options for many patients with metastatic ovarian cancer. Some individuals may achieve remission, while others may experience periods of stability with ongoing management. Regular follow-up care and monitoring can allow for timely treatment plan adjustments as needed to control any side effects or complications. With personalized treatment and supportive care, many patients can maintain a good quality of life and continue their daily activities.

Related Topics & Advanced Care

If you are looking for more detailed information about how ovarian cancer spreads beyond the primary site, explore our dedicated patient resources:

• What Is Metastatic Ovarian Cancer? – Learn how advanced-stage cancer cells travel and behave in the body.
• Where Does Metastatic Ovarian Cancer Spread To? – A breakdown of common metastatic sites, including the abdomen, lymph nodes, and lungs.
• What Happens When Ovarian Cancer Spreads? – What to expect regarding symptoms, diagnostic tracking, and advanced management options.

Benefit From World-Class Care at Moffitt Cancer Center

As a National Cancer Institute-designated Comprehensive Cancer Center, Moffitt is firmly positioned at the forefront of cancer research. Our scientists and clinicians are committed to advancing the treatment options for all stages of ovarian cancer through our robust clinical trials program, which provides our patients with unique opportunities to be among the first to benefit from promising new therapies that are not yet widely available.

If you would like to learn more about ovarian cancer stages, you can request an appointment with a specialist in our gynecological clinic by calling 1-888-663-3488 or submitting a new patient registration form online. We do not require referrals.